MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
An Interview With John Lasala, MD, PhD
Dr. Lasala shares his take on PFO and migraine, where cardiology needs to go next, and what it means to be a principal investigator.
By John Lasala, MD, PhD
Boston Scientific Cleared to Market Guidezilla Guide Extension Catheter
July 12, 2013—Boston Scientific Corporation (Natick, MA) announced that it has received US Food and Drug Administration 510(k) clearance and CE Mark approval for the Guidezilla guide extension catheter.
Abiomed Receives FDA Clearance for Higher-Flow Impella CP Heart Pump
September 10, 2012—Abiomed, Inc. (Danvers, MA) announced that it has received 510(k) clearance from the US Food and Drug Administration for a new higher-flow version of its percutaneous, catheter-based Impella heart pump.
Chronic Total Occlusions
By Ted E. Feldman, MD, FSCAI, Chief Medical Editor
Innovations
A preview of today's new products.
Percutaneous Management of Atrial Septal Defects
Percutaneous closure of ASDs yields results comparable to surgery in appropriate cases.
By Alan Zajarias, MD, and John M. Lasala, MD, PhD
Indications for Left-to-Right Shunt Closure
How closure of ASD, VSD, PFO, and PDA may lead to prevention or improvement of symptoms.
By Sudeshna Banerjee, MD, and John M. Lasala, MD, PHD, FACC
CHIEF MEDICAL EDITOR'S PAGE: Structural Heart Closure
By Ted E. Feldman, MD, FSCAI
Structural and Valvular Heart Disease
By Ted E. Feldman, MD, Chief Medical Editor
Drug-Eluting Stents in Coronary CTOs
Recommendations for treating patients with CTOs using new DES technology.
By Rajesh M. Dave, MD, FACC, FSCAI
